A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults
Stopped Strategic decision made by the company
Conditions
- Shingles
- Herpes Zoster Infection
- Human
Interventions
- BIOLOGICAL: Candidate 1: PF-07915234: VZV modRNA Powder for Suspension for Injection
- BIOLOGICAL: Candidate 1: PF-07915234: VZV modRNA Suspension for Injection
- BIOLOGICAL: Candidate 2: PF-07921188: VZV modRNA Suspension for Injection
- BIOLOGICAL: Candidate 3: PF-07921186: VZV modRNA Suspension for Injection
- BIOLOGICAL: Shingrix
- BIOLOGICAL: Candidate 2: PF-07921188: VZV modRNA Powder for Suspension for Injection
Sponsor
Pfizer
Collaborators